Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGK1 | P00558 | 1/20 | 0.57 |
| ▸ | PGK2 | P07205 | 1/20 | 0.57 |
| ▸ | PGD | P52209 | 5/20 | 0.53 |
| ▸ | MPI | P34949 | 1/20 | 0.39 |
| ▸ | LAP3 | P28838 | 2/20 | 0.37 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.35 |
| ▸ | TPI1 | P60174 | 1/20 | 0.34 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.33 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.33 |
| ▸ | LPAR4 | Q99677 | 1/20 | 0.33 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.33 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.33 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL80335 | 1.00 | PGK1 (0.57) | PGK1PGK2PGDMPILAP3 | |
| SCHEMBL30852238 | 1.00 | PGK1 (0.57) | PGK1PGK2PGDMPILAP3 | |
| SCHEMBL31657225 | 0.98 | PGK1 (0.55) | PGK1PGK2PGDMPILAP3 | |
| Phosphoric Acid SCHEMBL5917775 | 0.98 | PGK1 (0.55) | PGK1PGK2PGDMPILAP3 | |
| SCHEMBL3488353 | 0.89 | PGK1 (0.45) | PGK1PGK2PGDLAP3 | |
| SCHEMBL13176646 | 0.86 | PGK1 (0.52) | PGK1PGK2PGDMPILAP3 | |
| SCHEMBL186958 | 0.84 | PGK1 (0.50) | PGK1PGK2PGDMPILAP3 | |
| SCHEMBL4867885 | 0.82 | PGK1 (0.44) | PGK1PGK2PGDMPILAP3 | |
| SCHEMBL7756355 | 0.81 | PGK1 (0.47) | PGK1PGK2PGDLAP3LPAR6 | |
| SCHEMBL14464207 | 0.78 | LAP3 (0.41) | PGK1PGK2PGDLAP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025072741-A1 | PRESERVATIVES FOR MOLECULAR SAMPLE ANALYSIS WITH SAMPLE COLLECTION DEVICES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-04-03 | — | — | WO | claimed |
| CN-114426795-B | High-solid epoxy paint, preparation method and application | 南通星辰合成材料有限公司 | 2023-07-25 | — | — | CN | claimed |
| CN-107184577-A | Application of phthalide compound in preparing medicine for improving oxygen delivery function of hemoglobin blood substitute | 中山大学 | 2017-09-22 | — | — | CN | claimed |
| CN-102027116-A | Production of ethanol from carbon dioxide and water using photosynthetic bacteria algae and greenhouse distillation | WEIFU LEE JAMES | 2011-04-20 | — | — | CN | claimed |
| WO-2025072741-A1 | PRESERVATIVES FOR MOLECULAR SAMPLE ANALYSIS WITH SAMPLE COLLECTION DEVICES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-04-03 | — | — | WO | disclosed |
| US-12209252-B2 | Transduction buffer | KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN (NL) | 2025-01-28 | — | — | US | disclosed |
| EP-3954390-B1 | TRANSDUCTION BUFFER | KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN (NL) | 2024-08-07 | — | — | EP | disclosed |
| CN-116381072-B | Biomarker for identifying sporadic gout and frequent gout and application thereof | 苏州艾麦锶生命科技有限公司 | 2024-05-31 | — | — | CN | disclosed |
| CN-117551030-A | Crystalline forms of N- (4- (4- (cyclopropylmethyl) piperazine-1-carbonyl) phenyl) quinoline-8-sulfonamide | 安吉奥斯医药品有限公司 | 2024-02-13 | — | — | CN | disclosed |
| CN-116983390-A | Process for preparing hemoglobin oxygen carrier by using novel cross-linking agent and application | 中国医学科学院输血研究所 | 2023-11-03 | — | — | CN | disclosed |
| CN-111372920-B | Crystalline forms of N- (4- (4- (cyclopropylmethyl) piperazine-1-carbonyl) phenyl) quinoline-8-sulfonamide | 安吉奥斯医药品有限公司 | 2023-10-20 | — | — | CN | disclosed |
| CN-116568281-A | Pharmaceutical preparation | 安吉奥斯医药品有限公司 | 2023-08-08 | — | — | CN | disclosed |
| US-20080200437-A1 | Polyphosphorylated inositol derivatives; allosteric effectors, cell signaling molecule analogs; hypoxia related diseases | UNIVERSITE DE STRASBOURG (FR) | 2008-08-21 | — | — | US | disclosed |
| US-20080200437-A1 | Polyphosphorylated inositol derivatives; allosteric effectors, cell signaling molecule analogs; hypoxia related diseases | UNIVERSITE DE STRASBOURG (FR) | 2008-08-21 | — | — | US | disclosed |
| US-20070207986-A1 | Delivering modified inositol hexaphosphate (IHP); enhance the ability of mammalian red blood cells to deliver oxygen, by delivering IHP to the cytoplasm of the red blood cells; cardiovascular and respiratory disorders | NORMOXYS, INC. | 2007-09-06 | — | — | US | disclosed |
| CN-1314423-C | Kudzuvine root containing capsule capable of regulating blood pressure and blood fat, preventing and treating cardiovascular and cerebrovascular diseases | WANG WEIDONG (CN) | 2007-05-09 | — | — | CN | disclosed |
| CN-1208053-C | Use of gaseous nitric oxide for the production of a therapeutic gas for the treatment of hemoglobinopathies | GEN HOSPITAL CORP (US) | 2005-06-29 | — | — | CN | disclosed |
| CN-1602926-A | Kudzuvine root containing capsule capable of regulating blood pressure and blood fat, preventing and treating cardiovascular and cerebrovascular diseases | WANG WEIDONG (CN) | 2005-04-06 | — | — | CN | disclosed |
| CN-1227485-A | Treatment of hemoglobinopathy | GEN HOSPITAL CORP (US) | 1999-09-01 | — | — | CN | disclosed |
| CN-1047312-A | MACROMOLECULAR ENDOPLASMIC RETICULUM | NIPPON OILS & FATS CO LTD (JP) | 1990-11-28 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080200437-A1 | Polyphosphorylated inositol derivatives; allosteric effectors, cell signaling molecule analogs; hypoxia related diseases | PPIP5K2, IP6K1, IP6K3 | PGK1 105/4885PGK2 112/4885PGD 271/4885 |
| US-12209252-B2 | Transduction buffer | STAT3, JAK2, CFTR | PGK1 2704/4885PGK2 1847/4885PGD 3176/4885 |
| US-20070207986-A1 | Delivering modified inositol hexaphosphate (IHP); enhance the ability of mammalian red blood cells to deliver oxygen, by delivering IHP to the cytoplasm of the red blood cells; cardiovascular and respiratory disorders | PPIP5K2, ITPA, INPP5B | PGK1 482/4885PGK2 434/4885PGD 124/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.